Activity Number and Title
20CE168 - Physical Therapy in the Care of Persons with Bleeding Disorders
June 15, 2021
5:00 PM Eastern, June 16, 2023
The estimated time to complete this activity is 90 minutes.
The purpose of this online learning module is to enable the learner to increase their knowledge on the musculoskeletal concerns, potential complications, and physical therapy management of bleeding disorders.
After providing a review of basic information about hemophilia and von Willebrand disease, this learning module describes signs and symptoms of hemophilic bleeding, the complications associated with recurrent bleeding, physical therapy interventions for acute and chronic musculoskeletal complications of hemophilia, and imaging techniques including X-ray, MRI, and musculoskeletal ultrasound, which may be used to assess musculoskeletal status in patients with bleeding disorders.
This enduring material is intended for physical therapists, physical therapist assistants, nurses, nurse practitioners, and other health care providers who are involved with the federally recognized U.S. Hemophilia Treatment Center, or HTC, network or otherwise engaged in comprehensive care and/or physical therapy management of individuals with hemophilia and other bleeding disorders.
This activity assumes that the learner possesses fundamental knowledge of the musculoskeletal and neurological systems and a basic understanding of bleeding disorders and the comprehensive care model. Learners who do not meet these criteria may wish to complete the PartnersPRN activity, "Understanding Hemophilia", prior to completion of this module on physical therapy and comprehensive care.
At the conclusion of this enduring material, the participants should be better able to:
- Summarize basic information on the clinical picture of hemophilia and von Willebrand disease
- Identify signs and symptoms of acute and chronic musculoskeletal bleeding including hemarthroses and muscle bleeding
- Evaluate the complications of recurrent hemarthroses including chronic synovitis, cartilage destruction, and hemophilic arthropathy
- Discuss physical therapy interventions for acute bleeding events and chronic musculoskeletal complications of bleeding disorders and how the multidisciplinary team can help implement these strategies to improve patient outcomes
- Differentiate imaging techniques and their use to assess musculoskeletal status in patients with bleeding disorders
- Stacie Akins, PT, MHS
- Kimberly Baumann, MPT
- Sherry Herman-Hilker, PT, MS
- Jennifer Newman, MSPT
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center on behalf of the Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
This activity (CPTA #22-302) has been approved by the California Physical Therapy Association (CPTA) for 0.15 CEUs. While many states recognize continuing education credits from CPTA, please verify with your state Board that these credits are acceptable in your state. To learn more about CPTA, visit https://www.ccapta.org.
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer